Evidence map›Paper›PMID 28091608›Full record

ArticleScientific reports2017

Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors.

Jan Jakubík, Alena Randáková, Pavel Zimčík, Esam E El-Fakahany, Vladimír Doležal

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Recessive CHRM5 variant as a potential cause of neurogenic bladder.American journal of medical genetics. Part A · 2023
    Article
  3. Article
  4. Article
  5. Predicting Residence Time of GPCR Ligands with Machine Learning.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  6. Article
  7. Review
  8. Novel long-acting antagonists of muscarinic ACh receptors.British journal of pharmacology · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jan JakubíkInstitute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
Alena RandákováInstitute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
Pavel ZimčíkInstitute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
Esam E El-FakahanyDepartment of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA (EEE).
Vladimír DoležalInstitute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
Czech Academy of Sciences · CZCzech Academy of Sciences, Institute of Physiology · CZUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interaction of orthosteric ligands with extracellular domain was described at several aminergic G protein-coupled receptors, including muscarinic acetylcholine receptors. The orthosteric antagonists quinuclidinyl benzilate (QNB) and N-methylscopolamine (NMS) bind to the binding pocket of the muscarinic acetylcholine receptor formed by transmembrane α-helices. We show that high concentrations of either QNB or NMS slow down dissociation of their radiolabeled species from all five subtypes of muscarinic acetylcholine receptors, suggesting allosteric binding. The affinity of NMS at the allosteric site is in the micromolar range for all receptor subtypes. Using molecular modelling of the M

Indexed as

AccelerationAnimalsBinding SitesCHO CellsCricetinaeCricetulusHumansKineticsLigandsModels, BiologicalMolecular Dynamics SimulationMutant ProteinsN-MethylscopolamineProtein BindingProtein DomainsProtein Structure, SecondaryLigandsMutant ProteinsN-MethylscopolamineReceptors, MuscarinicTritium

Identifiers

PMID28091608
PMCPMC5238504
OpenAlexW2574507094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.